iomeprol has been researched along with Leanness in 1 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faggioni, L | 1 |
| Neri, E | 1 |
| Sbragia, P | 1 |
| Pascale, R | 1 |
| D'Errico, L | 1 |
| Caramella, D | 1 |
| Bartolozzi, C | 1 |
1 other study available for iomeprol and Leanness
| Article | Year |
|---|---|
80-kV pulmonary CT angiography with 40 mL of iodinated contrast material in lean patients: comparison of vascular enhancement with iodixanol (320 mg I/mL)and iomeprol (400 mg I/mL).
Topics: Aged; Aged, 80 and over; Angiography; Body Mass Index; Carcinoma, Non-Small-Cell Lung; Contrast Medi | 2012 |